Browse by category

Allurion launches AllurionMeds first AI-native compounded GLP-1 program

Allurion Technologies has launched AllurionMeds, a unique offering to patients that combines affordable and accessible weight loss...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

Dec 19

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

Dec 19

Racial and ethnic groups face barriers to obtaining OMMs

Dec 19

Weekly Digest